BAM
MRTX

Belpointe Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Belpointe Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-208
Closed -$7.73K – 3616
2023
Q1 		$7.73K Hold
208
– – ﹤0.01% 2847
2022
Q4 		$9.42K Buy
+208
New +$9.42K ﹤0.01% 2647